Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Non-Current Debt: 2020-2024

Historic Non-Current Debt for Journey Medical (DERM) over the last 4 years, with Dec 2024 value amounting to $24.9 million.

  • Journey Medical's Non-Current Debt fell 1.27% to $19.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.5 million, marking a year-over-year decrease of 1.27%. This contributed to the annual value of $24.9 million for FY2024, which is 70.15% up from last year.
  • According to the latest figures from FY2024, Journey Medical's Non-Current Debt is $24.9 million, which was up 70.15% from $14.6 million recorded in FY2023.
  • In the past 5 years, Journey Medical's Non-Current Debt registered a high of $24.9 million during FY2024, and its lowest value of $5.2 million during FY2020.
  • Moreover, its 3-year median value for Non-Current Debt was $19.8 million (2022), whereas its average is $19.8 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first dropped by 26.25% in 2023, then spiked by 70.15% in 2024.
  • Over the past 4 years, Journey Medical's Non-Current Debt (Yearly) stood at $5.2 million in 2020, then reached $19.8 million in 2022, then declined by 26.25% to $14.6 million in 2023, then soared by 70.15% to $24.9 million in 2024.